HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
198533.0,298618,2179-09-16 07:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 EKG - At [**2179-9-15**] 10:37 PM
   admit overnight. stable, with f/u portable CXR that showed no worsening
   of PTX.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-16**] 04:15 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-16**] 07:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 66 (63 - 76) bpm
   BP: 114/51(67) {99/44(59) - 114/61(71)} mmHg
   RR: 12 (12 - 23) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,790 mL
                                                                    410 mL
   Urine:
                                                                    340 mL
                                                                    410 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,790 mL
                                                                   -410 mL
   Respiratory support
   O2 Delivery Device: Non-rebreather
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   Gen- AOx3, NAD
   HEENT- NCAT, no JVD, +scleral icterus
   Pulm- B/L posterior rales, equal BS b/l.  Prolonged inspiratory phase,
   with short expiratory phase
   CV- S1/S2 no MGR
   Abd- soft, NTND
   Ext- 1+ LE edema b/l
   Skin -jaundiced
   Labs / Radiology
   38 K/uL
   11.1 g/dL
   93 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.8 mEq/L
   22 mg/dL
   99 mEq/L
   133 mEq/L
   30.0 %
   4.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
   WBC
   5.2
   4.8
   Hct
   32.5
   31.3
   30.0
   Plt
   47
   38
   Cr
   1.3
   1.2
   TropT
   <0.01
   <0.01
   Glucose
   94
   93
   Other labs: PT / PTT / INR:20.1/39.2/1.9, CK / CKMB /
   Troponin-T:48//<0.01, ALT / AST:26/52, Alk Phos / T Bili:72/7.2,
   Differential-Neuts:70.4 %, Lymph:14.0 %, Mono:9.5 %, Eos:5.5 %, Lactic
   Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:262 IU/L, Ca++:8.3 mg/dL,
   Mg++:1.7 mg/dL, PO4:3.9 mg/dL
   Imaging: CXR:small apical PTX b/l, L pleural effusion unchanged from
   prior.
   Microbiology: Bcx [**9-15**]: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   .
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: drop in Hct from 36 to 30 today, INR 1.9. Unclear etiology,
   possible bleeding vs DIC
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   -check DIC labs
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX but will also ROMI with
   serial enzymes. No ECG changes to suggest ischemia, cardiac enzymes
   negative x 2 and no PE on CTA
   - ROMI, CE's this AM
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level.
   - CBC at noon
   - continue to monitor
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: per patient is at baseline but much more significant on
   exam since previously documented
   - check LE duplex
   ICU Care
   Nutrition:
   Comments: Low Na diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments: patient and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor in PM
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 EKG - At [**2179-9-15**] 10:37 PM
   admit overnight. stable, with f/u portable CXR that showed no worsening
   of PTX.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-16**] 04:15 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-16**] 07:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 66 (63 - 76) bpm
   BP: 114/51(67) {99/44(59) - 114/61(71)} mmHg
   RR: 12 (12 - 23) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,790 mL
                                                                    410 mL
   Urine:
                                                                    340 mL
                                                                    410 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,790 mL
                                                                   -410 mL
   Respiratory support
   O2 Delivery Device: Non-rebreather
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   Gen- AOx3, NAD
   HEENT- NCAT, no JVD, +scleral icterus
   Pulm- B/L posterior rales, equal BS b/l.  Prolonged inspiratory phase,
   with short expiratory phase
   CV- S1/S2 no MGR
   Abd- soft, NTND
   Ext- 1+ LE edema b/l
   Skin -jaundiced
   Labs / Radiology
   38 K/uL
   11.1 g/dL
   93 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.8 mEq/L
   22 mg/dL
   99 mEq/L
   133 mEq/L
   30.0 %
   4.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
   WBC
   5.2
   4.8
   Hct
   32.5
   31.3
   30.0
   Plt
   47
   38
   Cr
   1.3
   1.2
   TropT
   <0.01
   <0.01
   Glucose
   94
   93
   Other labs: PT / PTT / INR:20.1/39.2/1.9, CK / CKMB /
   Troponin-T:48//<0.01, ALT / AST:26/52, Alk Phos / T Bili:72/7.2,
   Differential-Neuts:70.4 %, Lymph:14.0 %, Mono:9.5 %, Eos:5.5 %, Lactic
   Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:262 IU/L, Ca++:8.3 mg/dL,
   Mg++:1.7 mg/dL, PO4:3.9 mg/dL
   Imaging: CXR:small apical PTX b/l, L pleural effusion unchanged from
   prior.
   Microbiology: Bcx [**9-15**]: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   .
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: drop in Hct from 36 to 30 today, INR 1.9. Unclear etiology,
   possible bleeding vs DIC
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   -check DIC labs
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX but will also ROMI with
   serial enzymes. No ECG changes to suggest ischemia, cardiac enzymes
   negative x 2 and no PE on CTA
   - ROMI, CE's this AM
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level.
   - CBC at noon
   - continue to monitor
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: per patient is at baseline but much more significant on
   exam since previously documented
   - check LE duplex
   ICU Care
   Nutrition:
   Comments: Low Na diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Pneumoboots
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments: patient and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor in PM<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 56-year-old male with cirrhosis of the liver, chronic thrombocytopenia, chronic renal failure, and a history of hepatitis C. He was admitted with bilateral pneumothorax (PTX) and a new left pleural effusion.

The patient's current vital signs are:

* Temperature: 37.2°C (98.9°F)
* Heart rate: 66 beats per minute (bpm)
* Blood pressure: 114/51 mmHg
* Respiratory rate: 12 breaths per minute (bpm)
* SpO2: 98%
* Heart rhythm: Sinus rhythm

The patient's physical examination reveals:

* General: Alert and oriented
* HEENT: No jaundice, no jugular venous distension
* Pulmonary: Bilateral posterior rales, equal breath sounds bilaterally
* Cardiovascular: S1/S2 heart sounds, no murmurs
* Abdomen: Soft, non-tender
* Extremities: 1+ left leg edema
* Skin: Jaundiced

Laboratory results show:

* White blood cell count: 5.2 K/μL
* Hemoglobin: 11.1 g/dL
* Platelet count: 47 K/μL
* Blood urea nitrogen: 25 mEq/L
* Creatinine: 1.3 mg/dL
* Lactic acid: 1.7 mmol/L
* Albumin: 2.8 g/dL
* LDH: 262 IU/L
* Calcium: 8.3 mg/dL
* Magnesium: 1.7 mg/dL
* Phosphorus: 3.9 mg/dL

The patient's chest X-ray shows a small apical pneumothorax bilaterally and a left pleural effusion.

The patient's medical conditions include:

* Pneumothorax, other (not hospital-acquired or traumatic)
* Pleural effusion, acute
* Cirrhosis of the liver, other
* Thrombocytopenia, chronic
* Renal failure, chronic

The patient's assessment and plan include:

* Continue 100% non-rebreather oxygen to enhance resorption of pneumothorax
* Call intensivist this morning
* Serial exams, repeat chest X-ray
* Monitor for signs of hemodynamic compromise
* Hold eltrombopag study medication due to unclear etiology
* Thoracentesis today for determination of transudate vs exudate
* Serial exams
* TTE to evaluate for portopulmonary hypertension
* Follow-up blood cultures
* Fresh frozen plasma ordered, check coagulation studies in the morning

Potential medical complications that can arise include:

* Pneumothorax progression or recurrence
* Pleural effusion progression or recurrence
* Thrombocytopenia worsening or bleeding
* Renal failure worsening or acute kidney injury
* Hepatic encephalopathy or bleeding
* Infection or sepsis
* Cardiac complications, such as arrhythmias or heart failure
* Respiratory complications, such as acute respiratory distress syndrome or pneumonia

It is essential to closely monitor the patient's condition and adjust the treatment plan accordingly to prevent or minimize these potential complications."
198533.0,298618,2179-09-16 07:53:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 EKG - At [**2179-9-15**] 10:37 PM
   admit overnight. stable, with f/u portable CXR that showed no worsening
   of PTX.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-16**] 04:15 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-16**] 07:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 66 (63 - 76) bpm
   BP: 114/51(67) {99/44(59) - 114/61(71)} mmHg
   RR: 12 (12 - 23) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,790 mL
                                                                    410 mL
   Urine:
                                                                    340 mL
                                                                    410 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,790 mL
                                                                   -410 mL
   Respiratory support
   O2 Delivery Device: Non-rebreather
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   38 K/uL
   11.1 g/dL
   93 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.8 mEq/L
   22 mg/dL
   99 mEq/L
   133 mEq/L
   30.0 %
   4.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
   WBC
   5.2
   4.8
   Hct
   32.5
   31.3
   30.0
   Plt
   47
   38
   Cr
   1.3
   1.2
   TropT
   <0.01
   <0.01
   Glucose
   94
   93
   Other labs: PT / PTT / INR:20.1/39.2/1.9, CK / CKMB /
   Troponin-T:48//<0.01, ALT / AST:26/52, Alk Phos / T Bili:72/7.2,
   Differential-Neuts:70.4 %, Lymph:14.0 %, Mono:9.5 %, Eos:5.5 %, Lactic
   Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:262 IU/L, Ca++:8.3 mg/dL,
   Mg++:1.7 mg/dL, PO4:3.9 mg/dL
   Imaging: CXR:small apical PTX b/l, L pleural effusion unchanged from
   prior.
   Microbiology: Bcx [**9-15**]: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   .
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: drop in Hct from 36 to 30 today, INR 1.9. Unclear etiology,
   possible bleeding vs DIC
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   -check DIC labs
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX but will also ROMI with
   serial enzymes. No ECG changes to suggest ischemia, cardiac enzymes
   negative x 2 and no PE on CTA
   - ROMI, CE's this AM
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level.
   - CBC at noon
   - continue to monitor
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: per patient is at baseline but much more significant on
   exam since previously documented
   - check LE duplex
   ICU Care
   Nutrition:
   Comments: Low Na diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT:
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments: patient and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 EKG - At [**2179-9-15**] 10:37 PM
   admit overnight. stable, with f/u portable CXR that showed no worsening
   of PTX.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-16**] 04:15 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-16**] 07:53 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 36.7
C (98
   HR: 66 (63 - 76) bpm
   BP: 114/51(67) {99/44(59) - 114/61(71)} mmHg
   RR: 12 (12 - 23) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,790 mL
                                                                    410 mL
   Urine:
                                                                    340 mL
                                                                    410 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,790 mL
                                                                   -410 mL
   Respiratory support
   O2 Delivery Device: Non-rebreather
   SpO2: 98%
   ABG: ///25/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   38 K/uL
   11.1 g/dL
   93 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.8 mEq/L
   22 mg/dL
   99 mEq/L
   133 mEq/L
   30.0 %
   4.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
   WBC
   5.2
   4.8
   Hct
   32.5
   31.3
   30.0
   Plt
   47
   38
   Cr
   1.3
   1.2
   TropT
   <0.01
   <0.01
   Glucose
   94
   93
   Other labs: PT / PTT / INR:20.1/39.2/1.9, CK / CKMB /
   Troponin-T:48//<0.01, ALT / AST:26/52, Alk Phos / T Bili:72/7.2,
   Differential-Neuts:70.4 %, Lymph:14.0 %, Mono:9.5 %, Eos:5.5 %, Lactic
   Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:262 IU/L, Ca++:8.3 mg/dL,
   Mg++:1.7 mg/dL, PO4:3.9 mg/dL
   Imaging: CXR:small apical PTX b/l, L pleural effusion unchanged from
   prior.
   Microbiology: Bcx [**9-15**]: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   .
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: drop in Hct from 36 to 30 today, INR 1.9. Unclear etiology,
   possible bleeding vs DIC
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   -check DIC labs
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX but will also ROMI with
   serial enzymes. No ECG changes to suggest ischemia, cardiac enzymes
   negative x 2 and no PE on CTA
   - ROMI, CE's this AM
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level.
   - CBC at noon
   - continue to monitor
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: per patient is at baseline but much more significant on
   exam since previously documented
   - check LE duplex
   ICU Care
   Nutrition:
   Comments: Low Na diet
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT:
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments: patient and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 56-year-old male with cirrhosis of the liver, chronic thrombocytopenia, and chronic renal failure, admitted with bilateral pneumothorax (PTX) and a new left pleural effusion. The etiology of the PTX is unclear, but it is not related to hospital-acquired or traumatic causes. The patient has been treated with 100% non-rebreather oxygen to enhance resorption of the PTX, and serial exams are planned. The pleural effusion is being further evaluated with thoracentesis, and the patient has been started on anticoagulation therapy.

Potential Medical Complications:

1. Respiratory Complications: The patient's bilateral PTX and pleural effusion may lead to respiratory failure, and the patient is at risk for further complications such as respiratory distress syndrome.
2. Hemodynamic Complications: The patient's chronic thrombocytopenia and chronic renal failure may increase the risk of bleeding and hypotension.
3. Infection Complications: The patient's pleural effusion may be infected, and the patient is at risk for developing sepsis and organ failure.
4. Cardiac Complications: The patient's chronic liver disease and cirrhosis may increase the risk of cardiac complications such as portopulmonary hypertension.
5. Neurological Complications: The patient's chronic liver disease and cirrhosis may increase the risk of neurological complications such as encephalopathy and seizures.
6. Gastrointestinal Complications: The patient's chronic liver disease and cirrhosis may increase the risk of gastrointestinal complications such as variceal bleeding and ascites.
7. Renal Complications: The patient's chronic renal failure may increase the risk of further renal decline and the need for dialysis.
8. Bleeding Complications: The patient's chronic thrombocytopenia and chronic liver disease may increase the risk of bleeding complications such as gastrointestinal bleeding and intracranial bleeding.

Based on the patient's condition, it is essential to continue monitoring his vital signs, respiratory status, and laboratory results closely to identify any potential complications early on and to initiate appropriate interventions to prevent or manage them."
198533.0,298618,2179-09-17 07:16:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2179-9-16**] 08:33 AM
 TRANSTHORACIC ECHO - At [**2179-9-16**] 10:34 AM
   IP did not see patient today despite plan with ID and plan with us to
   do so, will see tomorrow morning.
   CXR yesterday showed worsening left lung volume loss which may be
   related to increasing large pleural effusion and small-to-moderate
   pneumothorax.  No DVT.  RUQ U/S: Patent portal vein. CE negative.
   DIC- fibrinogen 156. Continues on NRB.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-17**] 03:47 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-17**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.3
   HR: 69 (62 - 75) bpm
   BP: 98/58(68) {94/45(59) - 121/68(81)} mmHg
   RR: 17 (12 - 20) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  2,300 mL
                                                                    360 mL
   Urine:
                                                                  2,300 mL
                                                                    360 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,300 mL
                                                                   -360 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   43 K/uL
   10.3 g/dL
   124 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.5 mEq/L
   23 mg/dL
   100 mEq/L
   133 mEq/L
   29.7 %
   3.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
                             [**2179-9-16**]  12:19 PM
                             [**2179-9-17**]  03:27 AM
   WBC
   5.2
   4.8
   4.4
   3.8
   Hct
   32.5
   31.3
   30.0
   29.8
   29.7
   Plt
   47
   38
   43
   43
   Cr
   1.3
   1.2
   1.2
   TropT
   <0.01
   <0.01
   <0.01
   Glucose
   94
   93
   124
   Other labs: PT / PTT / INR:19.8/37.7/1.8, CK / CKMB /
   Troponin-T:30//<0.01, ALT / AST:26/49, Alk Phos / T Bili:73/5.3,
   Differential-Neuts:71.0 %, Lymph:14.3 %, Mono:8.2 %, Eos:6.2 %,
   Fibrinogen:157 mg/dL, Lactic Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:244
   IU/L, Ca++:8.3 mg/dL, Mg++:1.7 mg/dL, PO4:3.0 mg/dL
   Imaging: CXR portable: improvement or no change in L PTX and effusion.
   No consolidation.
   Microbiology: Bcx: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - call IP this AM
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: Hct stable o/n INR 1.8. Unclear etiology, possible bleeding
   vs DIC.  DIC labs WNL.
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX. ROMI.
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level. Plts stable o/n.
   - continue to monitor w/ daily CBC
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: No DVT
   ICU Care
   Nutrition:
   Comments: Low Na diet.
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments: PT and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2179-9-16**] 08:33 AM
 TRANSTHORACIC ECHO - At [**2179-9-16**] 10:34 AM
   IP did not see patient today despite plan with ID and plan with us to
   do so, will see tomorrow morning.
   CXR yesterday showed worsening left lung volume loss which may be
   related to increasing large pleural effusion and small-to-moderate
   pneumothorax.  No DVT.  RUQ U/S: Patent portal vein. CE negative.
   DIC- fibrinogen 156. Continues on NRB.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-17**] 03:47 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-17**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.3
   HR: 69 (62 - 75) bpm
   BP: 98/58(68) {94/45(59) - 121/68(81)} mmHg
   RR: 17 (12 - 20) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  2,300 mL
                                                                    360 mL
   Urine:
                                                                  2,300 mL
                                                                    360 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,300 mL
                                                                   -360 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   43 K/uL
   10.3 g/dL
   124 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.5 mEq/L
   23 mg/dL
   100 mEq/L
   133 mEq/L
   29.7 %
   3.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
                             [**2179-9-16**]  12:19 PM
                             [**2179-9-17**]  03:27 AM
   WBC
   5.2
   4.8
   4.4
   3.8
   Hct
   32.5
   31.3
   30.0
   29.8
   29.7
   Plt
   47
   38
   43
   43
   Cr
   1.3
   1.2
   1.2
   TropT
   <0.01
   <0.01
   <0.01
   Glucose
   94
   93
   124
   Other labs: PT / PTT / INR:19.8/37.7/1.8, CK / CKMB /
   Troponin-T:30//<0.01, ALT / AST:26/49, Alk Phos / T Bili:73/5.3,
   Differential-Neuts:71.0 %, Lymph:14.3 %, Mono:8.2 %, Eos:6.2 %,
   Fibrinogen:157 mg/dL, Lactic Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:244
   IU/L, Ca++:8.3 mg/dL, Mg++:1.7 mg/dL, PO4:3.0 mg/dL
   Imaging: CXR portable: improvement or no change in L PTX and effusion.
   No consolidation.
   Microbiology: Bcx: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - call IP this AM
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: Hct stable o/n INR 1.8. Unclear etiology, possible bleeding
   vs DIC.  DIC labs WNL.
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX. ROMI.
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level. Plts stable o/n.
   - continue to monitor w/ daily CBC
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: No DVT
   ICU Care
   Nutrition:
   Comments: Low Na diet.
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments: PT and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 56-year-old male with Hepatitis C cirrhosis, chronic thrombocytopenia, and chronic renal failure admitted with bilateral (B/L) pneumothorax (PTX) and a new left pleural effusion. The etiology of the PTX is unclear, but it is not related to recent pressure changes or known risk factors. The patient has a history of mild bullous disease on chest CT, which may have ruptured, leading to the PTX. The pleural effusion is moderate to large and has developed since admission, with a differential diagnosis including hemothorax, empyema, and parapneumonic effusion.

The patient's condition is stable, with a normal temperature, blood pressure, and heart rate. The patient is receiving 100% non-rebreather oxygen to enhance resorption of the PTX, and serial exams and repeat PA and lateral chest X-rays are planned. The patient is also being monitored for signs of hemodynamic compromise.

Potential medical complications that can arise:

1. Respiratory failure: The patient's PTX and pleural effusion can lead to respiratory failure if not managed properly.
2. Hemodynamic compromise: The patient's cardiac status and liver disease make them susceptible to hemodynamic compromise, which can be exacerbated by the PTX and pleural effusion.
3. Infection: The patient's pleural effusion may be infected, which can lead to sepsis and other complications.
4. Bleeding: The patient's thrombocytopenia and liver disease make them susceptible to bleeding, which can be exacerbated by the PTX and pleural effusion.
5. Renal failure: The patient's chronic renal failure can worsen if not managed properly, leading to further complications.
6. Liver failure: The patient's cirrhosis can worsen if not managed properly, leading to liver failure and other complications.
7. Cardiovascular complications: The patient's cardiac status and liver disease make them susceptible to cardiovascular complications, such as heart failure and arrhythmias."
198533.0,298618,2179-09-17 07:16:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2179-9-16**] 08:33 AM
 TRANSTHORACIC ECHO - At [**2179-9-16**] 10:34 AM
   IP did not see patient today despite plan with ID and plan with us to
   do so, will see tomorrow morning.
   CXR yesterday showed worsening left lung volume loss which may be
   related to increasing large pleural effusion and small-to-moderate
   pneumothorax.  No DVT.  RUQ U/S: Patent portal vein. CE negative.
   DIC- fibrinogen 156. Continues on NRB.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-17**] 03:47 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-17**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.3
   HR: 69 (62 - 75) bpm
   BP: 98/58(68) {94/45(59) - 121/68(81)} mmHg
   RR: 17 (12 - 20) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  2,300 mL
                                                                    360 mL
   Urine:
                                                                  2,300 mL
                                                                    360 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,300 mL
                                                                   -360 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   Gen-AOx3, NAD
   HEENT- scleral icterus, NCAT
   Pulm- crackles on L posterior lung, bilaterally equal lung expansion
   CV- RRR no mgr
   Abd- soft, NTND
   Ext- 1+LE edema
   Labs / Radiology
   43 K/uL
   10.3 g/dL
   124 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.5 mEq/L
   23 mg/dL
   100 mEq/L
   133 mEq/L
   29.7 %
   3.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
                             [**2179-9-16**]  12:19 PM
                             [**2179-9-17**]  03:27 AM
   WBC
   5.2
   4.8
   4.4
   3.8
   Hct
   32.5
   31.3
   30.0
   29.8
   29.7
   Plt
   47
   38
   43
   43
   Cr
   1.3
   1.2
   1.2
   TropT
   <0.01
   <0.01
   <0.01
   Glucose
   94
   93
   124
   Other labs: PT / PTT / INR:19.8/37.7/1.8, CK / CKMB /
   Troponin-T:30//<0.01, ALT / AST:26/49, Alk Phos / T Bili:73/5.3,
   Differential-Neuts:71.0 %, Lymph:14.3 %, Mono:8.2 %, Eos:6.2 %,
   Fibrinogen:157 mg/dL, Lactic Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:244
   IU/L, Ca++:8.3 mg/dL, Mg++:1.7 mg/dL, PO4:3.0 mg/dL
   Imaging: CXR portable: improvement or no change in L PTX and effusion.
   No consolidation.
   Microbiology: Bcx: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - call IP this AM
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: Hct stable o/n INR 1.8. Unclear etiology, possible bleeding
   vs DIC.  DIC labs WNL.
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX. ROMI.
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level. Plts stable o/n.
   - continue to monitor w/ daily CBC
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: No DVT
   ICU Care
   Nutrition:
   Comments: Low Na diet.
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments: PT and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 ULTRASOUND - At [**2179-9-16**] 08:33 AM
 TRANSTHORACIC ECHO - At [**2179-9-16**] 10:34 AM
   IP did not see patient today despite plan with ID and plan with us to
   do so, will see tomorrow morning.
   CXR yesterday showed worsening left lung volume loss which may be
   related to increasing large pleural effusion and small-to-moderate
   pneumothorax.  No DVT.  RUQ U/S: Patent portal vein. CE negative.
   DIC- fibrinogen 156. Continues on NRB.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2179-9-17**] 03:47 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2179-9-17**] 07:16 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.4
C (99.4
   Tcurrent: 37.4
C (99.3
   HR: 69 (62 - 75) bpm
   BP: 98/58(68) {94/45(59) - 121/68(81)} mmHg
   RR: 17 (12 - 20) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                  PO:
                  TF:
   IVF:
   Blood products:
   Total out:
                                                                  2,300 mL
                                                                    360 mL
   Urine:
                                                                  2,300 mL
                                                                    360 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,300 mL
                                                                   -360 mL
   Respiratory support
   O2 Delivery Device: Aerosol-cool
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   Gen-AOx3, NAD
   HEENT- scleral icterus, NCAT
   Pulm- crackles on L posterior lung, bilaterally equal lung expansion
   CV- RRR no mgr
   Abd- soft, NTND
   Ext- 1+LE edema
   Labs / Radiology
   43 K/uL
   10.3 g/dL
   124 mg/dL
   1.2 mg/dL
   25 mEq/L
   3.5 mEq/L
   23 mg/dL
   100 mEq/L
   133 mEq/L
   29.7 %
   3.8 K/uL
        [image002.jpg]
                             [**2179-9-15**]  10:01 PM
                             [**2179-9-16**]  04:12 AM
                             [**2179-9-16**]  05:56 AM
                             [**2179-9-16**]  12:19 PM
                             [**2179-9-17**]  03:27 AM
   WBC
   5.2
   4.8
   4.4
   3.8
   Hct
   32.5
   31.3
   30.0
   29.8
   29.7
   Plt
   47
   38
   43
   43
   Cr
   1.3
   1.2
   1.2
   TropT
   <0.01
   <0.01
   <0.01
   Glucose
   94
   93
   124
   Other labs: PT / PTT / INR:19.8/37.7/1.8, CK / CKMB /
   Troponin-T:30//<0.01, ALT / AST:26/49, Alk Phos / T Bili:73/5.3,
   Differential-Neuts:71.0 %, Lymph:14.3 %, Mono:8.2 %, Eos:6.2 %,
   Fibrinogen:157 mg/dL, Lactic Acid:1.7 mmol/L, Albumin:2.8 g/dL, LDH:244
   IU/L, Ca++:8.3 mg/dL, Mg++:1.7 mg/dL, PO4:3.0 mg/dL
   Imaging: CXR portable: improvement or no change in L PTX and effusion.
   No consolidation.
   Microbiology: Bcx: pending
   Assessment and Plan
 PNEUMOTHORAX, OTHER (NOT HOSPITAL ACQUIRED OR TRAUMATIC)
 PLEURAL EFFUSION, ACUTE
 CIRRHOSIS OF LIVER, OTHER
 THROMBOCYTOPENIA, CHRONIC
 RENAL FAILURE, CHRONIC (CHRONIC RENAL FAILURE, CRF, CHRONIC KIDNEY
   DISEASE)
   Assessment and Plan: This is a 56M with Hep C cirrhosis admitted with
   B/L PTX and new left effusion
   .
   # B/L PTX: Unclear etiology for new onset bilateral PTX given he has
   had no recent pressure changes that would precipitate PTX and no known
   risk factors for secondary PTX such as COPD, CF, TB, ankylosing
   spondylitis, asthma, histiocytosis X, idiopathic pulmonary fibrosis,
   lymphangioleiomyomatosis, lung cancer, Marfan syndrome, necrotizing
   pneumonia, rheumatoid arthritis, or sarcoidosis. Primary spontaneous
   PTX also possibility but he is not of typical stature, or epidemiology.
   He has no previous known underlying lung disease although likely had
   ruputure of subpleural bleb given mild bullous disease on chest CT
   which is out of proportion to smoking history.  He has been on new
   medication which stimulates megakaryocytes for thrombocytopenia but PTX
   or cystic lung disease not obvious side effect.
   - Continue 100% NRB to enhance resorption of PTX
   - Call IP this AM
   - serial exams, repeat PA and lateral CXR
   - monitor for any signs of hemodynamic compromise such as tachycardia,
   hypotension
   - Hold Eltrombopag study medication since unclear if this is underlying
   cause (Dr. [**Last Name (STitle) 1174**]
   # Pleural effusion: Pt has chronic small right effusion likely from
   known liver disease but has new moderate to large left pleural effusion
   which has developed since 6/[**2179**]. unclear if related to new PTX but
   Differential includes hemothorax related to , empyema and parapneumonic
   effusion, transudative effusion. Given no infectious symptoms such as
   fever, chills, leukocytosis will not continue abx started in ED but
   would pursue further workup with thoracentesis for determination of
   transudate vs exudate with cytology, cell counts, cx and gram stain.
   Unlikely new heart failure or related to cirrhosis since assymmetric
   and left>right.
   - call IP this AM
   - Thoracentesis today with cx, gram stain, cytology,
   - serial exams
   - TTE to eval for portopulmonary HTN
   - f/u blood cx
   - FFP ordered, check coags in am, has active type and screen
   # Anemia: Hct stable o/n INR 1.8. Unclear etiology, possible bleeding
   vs DIC.  DIC labs WNL.
   -guaiac stool
   -CT scan show hundsfield units of pleural fluid not consistent with
   blood
   - FFP ordered, follow coags, has active type and screen and 1 unit on
   hold
   # CP: Dyspnea and CP likely secondary to PTX. ROMI.
   - repeat ECG in am
   - controlled with PRN morphine
   # Cirrhosis: [**3-15**] hep C acquired from blood transfusion. Stable. No
   active issues
   - continue nadolol for history of varices, cipro for SBP ppx,
   lactulose, rifaximin, lasix, and aldactone
   - appreciate liver following while in house (call c/s)
   # Thrombocytopenia: Stable at baseline. Transfused platelets yesterday,
   plt #back to pre-txf level. Plts stable o/n.
   - continue to monitor w/ daily CBC
   # HTN: Currently well controlled on home meds of lasix and aldactone,
   nadolol
   # R>L LE edema: No DVT
   ICU Care
   Nutrition:
   Comments: Low Na diet.
   Glycemic Control:
   Lines:
   20 Gauge - [**2179-9-15**] 09:25 PM
   Prophylaxis:
   DVT: Boots
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments: PT and wife
   [**Name (NI) 36**] status: Full code
   Disposition:Transfer to floor<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 56-year-old male with a history of Hepatitis C cirrhosis, chronic thrombocytopenia, and chronic renal failure. He was admitted with bilateral pleural effusion and new onset of left pleural effusion.

The patient's current condition is as follows:

* Respiratory: He has a moderate to large left pleural effusion and a small right effusion. He is receiving 100% NRB to enhance resorption of the effusion.
* Cardiovascular: He has a history of cirrhosis and is on medication for portopulmonary hypertension.
* Hematological: He has chronic thrombocytopenia and was transfused with platelets yesterday. His platelet count is stable at baseline.
* Renal: He has chronic renal failure and is on medication for hypertension.
* Liver: He has cirrhosis due to Hepatitis C and is on medication for varices, spontaneous bacterial peritonitis prophylaxis, and liver function.
* Infectious: He has no signs of infection, such as fever, chills, or leukocytosis.

Potential medical complications that can arise from the patient's conditions include:

1. Respiratory failure due to the large left pleural effusion, which can lead to respiratory distress and hypoxia.
2. Cardiac complications due to portopulmonary hypertension, which can lead to cardiac failure and arrhythmias.
3. Hemorrhagic complications due to thrombocytopenia, which can lead to bleeding and hematoma formation.
4. Renal failure exacerbation due to the patient's pre-existing chronic renal failure, which can lead to electrolyte imbalances and acidosis.
5. Liver failure exacerbation due to the patient's cirrhosis, which can lead to encephalopathy, ascites, and bleeding.
6. Infection complications due to the patient's immunocompromised state, which can lead to sepsis and multi-organ failure.

The patient's current medications include:

* NRB (100%) for respiratory support
* Morphine sulfate for pain management
* Eltrombopag for thrombocytopenia
* Lasix for hypertension
* Aldactone for hypertension
* Nadolol for varices prophylaxis
* Cipro for spontaneous bacterial peritonitis prophylaxis
* Lactulose for liver function
* Rifaximin for liver function
* FFP (fresh frozen plasma) for bleeding prophylaxis

The patient's plan of care includes:

* Continue 100% NRB to enhance resorption of the pleural effusion
* Call the intensivist this morning
* Serial exams and repeat PA and lateral CXR
* Monitor for any signs of hemodynamic compromise
* Hold Eltrombopag study medication since unclear if it is the underlying cause
* Thoracentesis today with CX, gram stain, and cytology
* TTE to evaluate for portopulmonary hypertension
* F/u blood CX
* FFP ordered, check coags in the morning
* Repeat ECG in the morning
* Controlled with PRN morphine"
